Registry-listed formulations

Estazolam · chembl:CHEMBL285674

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

2 source entries across 2 studies. This list may not include all unresolved or historical entries.

  • Estazolam 1Mg TabRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • estazolam 1-2 mgRegistry intervention

    Linked study entry; product equivalence not established

    View study and source

Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(17%)
Results Posted
0%(0 trials)

Phase Distribution

Phase 4
2
33%
Not Applicable
2
33%
Phase 3
2
33%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
2(33.3%)
Phase 4Post-market surveillance
2(33.3%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(3)
Other(1)

Detailed Status

Completed3
Not yet recruiting1
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 32 (33.3%)
Phase 42 (33.3%)
N/A2 (33.3%)

Trials by Status

not_yet_recruiting117%
recruiting117%
unknown117%
completed350%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
Drug
Molecule Type
Small molecule
Total Trials
6

External References

Names & Codes

ATC Classification

Research Codes

ABBOTT-47631NSC-290818